Arch Therapeutics, Inc.
ARTHQ
$0.0001
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -210.17% | -62.78% | -48.98% | -30.11% | -74.16% |
| Total Depreciation and Amortization | 33.33% | 50.00% | 0.00% | -12.50% | -62.50% |
| Total Amortization of Deferred Charges | -34.54% | -11.05% | 173.16% | 175.07% | -- |
| Total Other Non-Cash Items | 9,516.46% | 100.00% | -75.10% | -65.03% | -54.52% |
| Change in Net Operating Assets | 42.38% | -62.25% | 15.35% | 295.53% | -34.34% |
| Cash from Operations | -1.57% | -16.72% | -32.69% | 26.52% | -56.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -4.04% | -13.79% | 4,650.00% | -129.99% | 72.17% |
| Total Debt Repaid | 1.69% | 1.88% | 1.88% | 3.67% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.13% | -15.84% | 1,079.95% | -42.09% | 66.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.68% | -1,049.21% | 97.70% | -80.32% | 9,400.00% |